Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 8, 2014, Pages 705-711

  Mailick, Marsha R ^a   Hong, Jinkuk ^a   Greenberg, Jan ^a   Smith, Leann ^a   Sherman, Stephanie ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; depression; FMR1 CGG repeats; FXPOI; Menopause; Premature ovarian failure; Premutation

Indexed keywords

FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN;

ADULT; AGE; AGED; FEMALE; FRAGILE X SYNDROME; GENETICS; HUMAN; MENOPAUSE; MIDDLE AGED; MUTATION; PHENOTYPE; PREMATURE OVARIAN FAILURE;

ADULT; AGE FACTORS; AGED; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MENOPAUSE; MIDDLE AGED; MUTATION; PHENOTYPE; PRIMARY OVARIAN INSUFFICIENCY;

EID: 84923577910     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32277     Document Type: Article

References (37)

1. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Sherman SL. 2007. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 22:2142-2152.
2. Bailey DB, Sideris J, Roberts J, Hatton D. 2008. Child and genetic variables associated with maternal adaptation to fragile X syndrome: A multidimensional analysis. Am J Med Genet Part A 146A:720-729.
3. Berry-Kravis E, Hall DA. 2011. Executive dysfunction in young FMR1 premutation carriers: Forme fruste of FXTAS or new phenotype? Neurology 77(7):612-321.
4. Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. 2005. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol 57:144-147.
5. Bione S, Benedetti S, Goegan M, Menditto I, Marozzi A, Ferrari M, Toniolo D. 2006. Skewed X-chromosome inactivation is not associated with premature ovarian failure in a large cohort of Italian patients. Am J Med Genet Part A 140:1349-1351.
6. Bodega B, Bione S, Dalpra L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E, Marozzi A. 2006. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 21:952-957.
7. Brown WT. 2002. The molecular biology of fragile X mutation. In 3rd ed. Baltimore: John Hopkins University Press. pp 110-135.
8. Ennis S, Ward D, Murray A. 2006. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 14:253-255.
9. Gold EB. 2011. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 425-440.
10. Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ. 2006. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243-255.
11. Grigsby J, Leehey MA, Jacquemont S, Brunberg JA, Hagerman RJ, Wilson R, Epstein JH, Greco CM, Tassone F, Hagerman PJ. 2006. Cognitive impairment in a 65-year old male with the Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Cogn Behav Neurol 3:165-167.
12. Hagerman PJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Laschiewicz A, Tranfaglia M. 2009. Advances in the treatment of fragile X syndrome. Pediatrics 123:378-390.
13. Hagerman PJ, Hagerman RJ. 2004. The fragile-X premutation: A maturing perspective. Am J Hum Genet 74:805-816.
14. Hartley S, Seltzer MM, Hong J, Greenberg J, Smith L, Almeida D, Coe C, Abbeduto L. 2011. Cortisol response to behavior problems in FMR1 premutation mothers of adolescents and adults with fragile X syndrome: A diathesis-stress model. Int J Behav Dev 36:53-61.
15. Hauser RM, Sheridan JT, Warren JR. 1999. Socioeconomic achievements of siblings in the life course: New findings from the Wisconsin Longitudinal Study. Res Aging 21:338-378.
16. Heine-Suner D, Torres-Juan L, Morla M, Busquets X, Barcelo F, Pico G, Bonilla L, Govea N, Bernues M, Rosell J. 2003. Fragile-X syndrome and skewed X-chromosome inactivation within a family: A female member with complete inactivation of the functional X chromosome. Am J Med Genet 122:108-114.
17. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ. 2005. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet Part B 139B:115-121.
18. Hoffman GE, Le WW Entezam, Otsuka N, Tong ZB, Nelson L, Flaws JA, McDonald JH, Jafar S, Usdin K. 2012. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem 60:439-456.
19. Leehey MA. 2009. Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): Clinical phenotype, diagnosis and treatment. J Investig Med 57 (8):830-836.
20. Loesch DZ, Bui MQ, Hammersley E, Schneider A, Storey E, Stimpson P, Burgess T, Francis D, Slater H, Tassone F, Hagerman RJ, Hessl D. 2014. Psychological status in female carriers of premtuation FMR1 allele showing a complex relationship with size of CGG expansion. Clin Genet doi:10.111/cage 12347.
21. Lu C, Lin L, Tan H, Wu H, Sherman SL, Gao F, Jin P, Chen D. 2012. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet 21(23):5039-5047.
22. Maenner M, Baker M, Broman K, Tian J, Barnes J, Atkins A, McPherson E, Hong J, Brilliant M, Mailick M. 2013. FMR1 CGG expansions: Prevalence and sex ratios Am J Med Genet Part B 162B:466-473.
23. Mailick MR, Greenberg JS, Smith L, Sterling A, Brady N, Warren SF, Hong J. Fragile X-associated disorders: How the family environment and genotype interact. In: Burack J, Schmidt L, editors, Cultural and contextual perspectives on development at risk. Cambridge: Cambridge University Press. In press.
24. Murray A. 2000. Premature ovarian failure and the FMR1 gene. Semin Reprod Med 18:59-66.
25. Roberts JE, Bailey DB, Mankowski J, Ford A, Sideris J, Weisenfeld LA, Golden RN. 2009. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet Part B 150B:130-139.
26. Rodriguez-Revenga L, Madrigal I, Badenas C, Xuncla M, Jimenez L, Mila M. 2009. Premature ovarian failure and fragile X female premutation carriers: No evidence for a skewed X-chromosome inactivation pattern. Menopause 16(5):944-949.
27. Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg JS, Mandel D. 2012a. Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet Part B 2159B:589-597.
28. Seltzer MM, Barker ET, Greenberg JS, Hong J, Coe C, Almeida D. 2012b. Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychol 31:612-622.
29. Sherman SL, Taylor K, Allen EG. 2007. FMR1 premutation: A leading cause of inherited ovarian dysfunction. In: Arrieta I, Penagarikano O, Telez M, editors, Fragile Sites: New Directions and Changing Perspectives. Hauppauge, NY: Nova Science Publishers. pp 299-320.
30. Shuster LLT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. 2010. Remature menopause or early menopause: Long-term health consequences. Maturitas 65(2):161-166.
31. Spath MA, Feuth TB, Smits AP, Yntema HG, Braat DD, Thomas CM, van Kessel AG, Sherman SL, Allen EG. 2011. Predictors and risk model development for menopausal age in fragile X premutation carriers. Genet Med 13(7):643-650.
32. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. 2005. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402-412.
33. Tassone F, Iong KP, Tong TH, Lo J, Gan LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ. 2012. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4:100.
34. Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ. 2007. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet Part B 144B:566-569.
35. Tejada MI, Garcia-Alegria E, Bilbao A, Martinez-Bouzas C, Beristain E, Poch M, Ramos-Arroyo MA, Lopez B, Fernandez Carvajal, Ribate I, Ramos MP. 2008. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause 15(5):945-949.
36. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. 2007. The FMR1 premutation and reproduction. Fertil Steril 87:456-465.
37. Yonker JA, Chang V, Roetker NS, Hauser TS, Hauser RM, Atwood CA. 2013. Hypothalamic-pituitary-gonadal axis homeostasis predicts longevity. Age 35(1):129-138.